Share-based Payment Arrangement, Noncash Expense of DNA X, Inc. from 31 Mar 2018 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of noncash expense for share-based payment arrangement.
- Summary
-
DNA X, Inc. quarterly and annual Share-based Payment Arrangement, Noncash Expense in USD history and change rate from 31 Mar 2018 to 31 Dec 2025.
- DNA X, Inc. Share-based Payment Arrangement, Noncash Expense for the quarter ending 31 Dec 2025 was $159,000, a 55% decline year-over-year.
- DNA X, Inc. Share-based Payment Arrangement, Noncash Expense for the twelve months ending 31 Dec 2025 was $1,541,000, a 1% increase year-over-year.
- DNA X, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2025 was $1,541,000, a 1% increase from 2024.
- DNA X, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2024 was $1,525,000, a 1.9% increase from 2023.
- DNA X, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2023 was $1,496,000, a 3.5% decline from 2022.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Noncash Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Noncash Expense, Quarterly (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Noncash Expense, Annual (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)
DNA X, Inc. Quarterly Share-based Payment Arrangement, Noncash Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $1,541,000 | $159,000 | -$197,000 | -55% | 01 Oct 2025 | 31 Dec 2025 | 10-K | 15 Apr 2026 | 2025 | FY |
| Q3 2025 | $1,738,000 | $166,000 | -$207,000 | -55% | 01 Jul 2025 | 30 Sep 2025 | 10-Q | 31 Oct 2025 | 2025 | Q3 |
| Q2 2025 | $1,945,000 | $926,000 | +$454,000 | +96% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 08 Aug 2025 | 2025 | Q2 |
| Q1 2025 | $1,491,000 | $290,000 | -$34,000 | -10% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 12 May 2025 | 2025 | Q1 |
| Q4 2024 | $1,525,000 | $356,000 | -$102,000 | -22% | 01 Oct 2024 | 31 Dec 2024 | 10-K | 15 Apr 2026 | 2025 | FY |
| Q3 2024 | $1,627,000 | $373,000 | +$2,000 | +0.54% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 31 Oct 2025 | 2025 | Q3 |
| Q2 2024 | $1,625,000 | $472,000 | +$114,000 | +32% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 08 Aug 2025 | 2025 | Q2 |
| Q1 2024 | $1,511,000 | $324,000 | +$15,000 | +4.9% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 12 May 2025 | 2025 | Q1 |
| Q4 2023 | $1,496,000 | $458,000 | 01 Oct 2023 | 31 Dec 2023 | 10-K | 31 Mar 2025 | 2024 | FY | ||
| Q3 2023 | $371,000 | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 13 Nov 2024 | 2024 | Q3 | |||
| Q2 2023 | $358,000 | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 09 Aug 2024 | 2024 | Q2 | |||
| Q1 2023 | $309,000 | +$26,000 | +9.2% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 14 May 2024 | 2024 | Q1 | |
| Q1 2022 | $283,000 | -$13,000 | -4.4% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 08 May 2023 | 2023 | Q1 | |
| Q1 2021 | $296,000 | +$73,000 | +33% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 10 May 2022 | 2022 | Q1 | |
| Q1 2020 | $223,000 | +$176,000 | +374% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 11 May 2021 | 2021 | Q1 | |
| Q1 2019 | $47,000 | +$14,000 | +42% | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 14 May 2020 | 2020 | Q1 | |
| Q1 2018 | $33,000 | 01 Jan 2018 | 31 Mar 2018 | 10-Q | 24 Jun 2019 | 2019 | Q1 |
DNA X, Inc. Annual Share-based Payment Arrangement, Noncash Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $1,541,000 | +$16,000 | +1% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 15 Apr 2026 | 2025 | FY |
| 2024 | $1,525,000 | +$29,000 | +1.9% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 15 Apr 2026 | 2025 | FY |
| 2023 | $1,496,000 | -$55,000 | -3.5% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 31 Mar 2025 | 2024 | FY |
| 2022 | $1,551,000 | +$466,000 | +43% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 27 Mar 2024 | 2023 | FY |
| 2021 | $1,085,000 | -$2,000 | -0.18% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 20 Mar 2023 | 2022 | FY |
| 2020 | $1,087,000 | -$5,221,000 | -83% | 01 Jan 2020 | 31 Dec 2020 | 10-K/A | 29 Jun 2022 | 2021 | FY |
| 2019 | $6,308,000 | +$6,056,000 | +2403% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 18 Mar 2021 | 2020 | FY |
| 2018 | $252,000 | 01 Jan 2018 | 31 Dec 2018 | 10-K | 27 Mar 2020 | 2019 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.